Aidan King

Aidan King is a Managing Partner and Co-Founder of Fountain Healthcare Partners, a transatlantic life science investment firm.2 He joined the board of directors at Ermium Therapeutics, a Paris-based biotech company developing innovative therapies for auto-immune diseases, in June 2022.1

Professional Background

Aidan King's background is in pharmacy, having qualified as a pharmacist from Trinity College Dublin.5 His career in the life sciences industry includes:

• Starting in pharmaceutical strategic marketing at Elan
• Moving to New York to work in Elan's corporate venture capital group
• Co-founding Fountain Healthcare Partners, where he primarily focuses on US investments, marketing, and fundraising2

Current Roles and Responsibilities

As a Managing Partner at Fountain Healthcare Partners, Aidan King:

• Focuses on US investments, marketing, and fundraising for the firm24
• Sits on the boards of several companies, including:
  • Ermium Therapeutics
  • XyloCore Therapeutics
  • Corteria Pharmaceuticals4

Involvement with Ermium Therapeutics

Aidan King joined Ermium Therapeutics' board of directors in June 2022 when Fountain Healthcare Partners participated in extending the company's initial funding from €6.3 million to €12.3 million.1 His appointment to the board coincided with this investment, demonstrating Fountain Healthcare Partners' commitment to advancing Ermium's innovative auto-immune disease therapeutics.16

Aidan King's LinkedIn profile can be found under the username aidan-king-86aa36, and he is based in New York, New York, United States.3